Ontology highlight
ABSTRACT:
SUBMITTER: Lima K
PROVIDER: S-EPMC6616334 | biostudies-literature | 2019 Jul
REPOSITORIES: biostudies-literature
Lima Keli K Carlos Jorge Antonio Elias Godoy JAEG Alves-Paiva Raquel de Melo RM Vicari Hugo Passos HP Souza Santos Fábio Pires de FP Hamerschlak Nelson N Costa-Lotufo Leticia Veras LV Traina Fabiola F Machado-Neto João Agostinho JA
Scientific reports 20190709 1
JAK2/STAT signaling participates in the Ph-negative myeloproliferative neoplasms (MPN) pathophysiology and has been targeted by ruxolitinib, a JAK1/2 inhibitor. In the present study, the impact of ruxolitinib treatment on cytoskeleton-related genes expression was explored. In SET2 cells, AURKA and AURKB expression/activity were downregulated in a dose- and time-dependent manner by ruxolitinib. Reversine, a multikinase inhibitor selective for aurora kinases, reduced cell viability in a dose- and/ ...[more]